Incremental benefit of sodium–glucose cotransporter 2 inhibitor and mineralocorticoid receptor antagonist therapy in HFpEF with moderate mitral regurgitation: 24-month ambulatory cohort study
29 August 2026 (10:15 - 11:00)
Organised by: 

About the speaker

University Hospital Alexandrovska, Sofia (Bulgaria)
7 More presentations in this session

Associate Professor Y. Shingu (Sapporo, JP)

Doctor C. Tsai (Taipei, TW)
Access the full session
The Event
ESC Congress 2026
29 August 2026
10:15 CET
You may be interested in
Congress Presentation
Congress Presentation
18 May 2025

Congress Presentation
Congress Presentation
24 May 2022





